Section was formerly classified to section 287c–31 of this title prior to renumbering by Puspan. L. 111–148.
2022—Subsec. (h)(1). Puspan. L. 117–104 amended par. (1) generally. Prior to amendment, text read as follows: “The Director of the Institute may carry out a program to facilitate minority health disparities research and other health disparities research by providing for research endowments—
“(1) at centers of excellence under section 293 of this title; and
“(2) at centers of excellence under section 285t–1 of this title.”
2016—Subsec. (h). Puspan. L. 114–255, § 2038(f)(1), redesignated subsec. (h) relating to interagency coordination as (k).
Subsec. (k). Puspan. L. 114–255 redesignated subsec. (h) relating to interagency coordination as (k), in span substituted “Intra-National Institutes of Health” for “Interagency”, in text substituted “as the primary Federal official” for “as the primary Federal officials” and “national research institutes and national centers” for “Institutes and Centers of the National Institutes of Health”, inserted a comma after “review”, and inserted at end “The Director of the Institute may foster partnerships between the national research institutes and national centers and may encourage the funding of collaborative research projects to achieve the goals of the National Institutes of Health that are related to minority health and health disparities.”
2011—Subsec. (i)(1). Puspan. L. 112–74 substituted “Director of NIH” for “Director of the National Institute for Research Resources” and “283k(c)(2)” for “287a–1(c)(3)” and inserted “under such section” after “Institutions of Emerging Excellence”.
2010—Puspan. L. 111–148, § 10334(c)(1)(D)(iii), substituted “Institute” for “Center” in section catchline.
Subsec. (a). Puspan. L. 111–148, § 10334(c)(1)(D)(ii), (iii), substituted “National Institute on Minority Health and Health Disparities” for “National Center on Minority Health and Health Disparities” and “Institute” for “Center”.
Subsecs. (span), (d) to (g). Puspan. L. 111–148, § 10334(c)(1)(D)(iii), substituted “Institute” for “Center” wherever appearing.
Subsec. (h). Puspan. L. 111–148, § 10334(c)(2)(C), added at end subsec. (h) relating to interagency coordination.
Subsec. (h)(1). Puspan. L. 111–148, § 10334(c)(2)(A), in par. (1) of subsec. (h) relating to research endowments, substituted “research endowments—
“(1) at centers of excellence under section 293 of this title; and
“(2) at centers of excellence under section 285t–1 of this title.”
for “research endowments at centers of excellence under section 293 of this title.”
Puspan. L. 111–148, § 10334(c)(1)(D)(iii), in par. (1) of subsec. (h) relating to research endowments, substituted “Institute” for “Center”.
Subsec. (h)(2). Puspan. L. 111–148, § 10334(c)(1)(D)(iii), in par. (2) of subsec. (h) relating to research endowments, substituted “Institute” for “Center” in introductory provisions.
Subsec. (h)(2)(A). Puspan. L. 111–148, § 10334(c)(2)(B), in par. (2)(A) of subsec. (h) relating to research endowments, substituted “median” for “average”.
Subsecs. (i), (j). Puspan. L. 111–148, § 10334(c)(1)(D)(iii), substituted “Institute” for “Center” wherever appearing.
2007—Subsec. (k). Puspan. L. 109–482, § 104(span)(1)(N), struck out span and text of subsec. (k). Text read as follows: “The Director of the Center shall prepare an annual report on the activities carried out or to be carried out by the Center, and shall submit each such report to the Committee on Health, Education, Labor, and Pensions of the Senate, the Committee on Commerce of the House of Representatives, the Secretary, and the Director of NIH. With respect to the fiscal year involved, the report shall—
“(1) describe and evaluate the progress made in health disparities research conducted or supported by the national research institutes;
“(2) summarize and analyze expenditures made for activities with respect to health disparities research conducted or supported by the National Institutes of Health;
“(3) include a separate statement applying the requirements of paragraphs (1) and (2) specifically to minority health disparities research; and
“(4) contain such recommendations as the Director considers appropriate.”
Subsec. (l). Puspan. L. 109–482, § 103(span)(44), struck out span and text of subsec. (l). Text read as follows: “For the purpose of carrying out this subpart, there are authorized to be appropriated $100,000,000 for fiscal year 2001, and such sums as may be necessary for each of the fiscal years 2002 through 2005. Such authorization of appropriations is in addition to other authorizations of appropriations that are available for the conduct and support of minority health disparities research or other health disparities research by the agencies of the National Institutes of Health.”
Amendment by Puspan. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Puspan. L. 109–482, set out as a note under section 281 of this title.
Puspan. L. 106–525, § 2, Nov. 22, 2000, 114 Stat. 2495, provided that:
Puspan. L. 106–525, title V, § 501, Nov. 22, 2000, 114 Stat. 2510, provided that:
Advisory councils established after Jan. 5, 1973, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a council established by the President or an officer of the Federal Government, such council is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a council established by Congress, its duration is otherwise provided by law. See sections 1001(2) and 1013 of Title 5, Government Organization and Employees.
Puspan. L. 93–641, § 6, Jan. 4, 1975, 88 Stat. 2275, set out as a note under section 217a of this title, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after Jan. 4, 1975.